A337840 Stock Overview
Develops and produces Gluco-Chaser, a continuous glucose monitoring system for managing type-I and type-II diabetes; and Always continuous glucose monitoring sensors. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
UXN Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩8,060.00 |
| 52 Week High | ₩19,500.00 |
| 52 Week Low | ₩7,650.00 |
| Beta | 0 |
| 11 Month Change | -10.54% |
| 3 Month Change | -38.71% |
| 1 Year Change | -56.05% |
| 33 Year Change | -66.76% |
| 5 Year Change | n/a |
| Change since IPO | -10.44% |
Recent News & Updates
Recent updates
Shareholder Returns
| A337840 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -10.3% | 6.1% | -2.8% |
| 1Y | -56.1% | 14.9% | -3.4% |
Return vs Industry: A337840 underperformed the KR Medical Equipment industry which returned 14.9% over the past year.
Return vs Market: A337840 underperformed the KR Market which returned -3.4% over the past year.
Price Volatility
| A337840 volatility | |
|---|---|
| A337840 Average Weekly Movement | 7.8% |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A337840 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A337840's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | n/a | Sejin Park | uxn.co.kr |
UXN Co., Ltd. develops and produces Gluco-Chaser, a continuous glucose monitoring system for managing type-I and type-II diabetes; and Always continuous glucose monitoring sensors. The company was founded in 2012 and is based in Suwon-si, South Korea.
UXN Co., Ltd. Fundamentals Summary
| A337840 fundamental statistics | |
|---|---|
| Market cap | ₩29.89b |
| Earnings (TTM) | ₩0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A337840 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A337840 income statement (TTM) | |
|---|---|
| Revenue | ₩0 |
| Cost of Revenue | ₩0 |
| Gross Profit | ₩0 |
| Other Expenses | ₩0 |
| Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A337840 perform over the long term?
See historical performance and comparison